Form 8-K - Current report:
SEC Accession No. 0000950123-10-066891
Filing Date
2010-07-21
Accepted
2010-07-21 16:54:31
Documents
2
Period of Report
2010-07-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c03672e8vk.htm 8-K 17854
2 EXHIBIT 99.1 c03672exv99w1.htm EX-99.1 253218
  Complete submission text file 0000950123-10-066891.txt   272723
Mailing Address 20425 SENECA MEADOWS PARKWAY, GERMANTOWN, MD 20876
Business Address 20425 SENECA MEADOWS PARKWAY GERMANTOWN MD 20878 (301) 944-6600
MiddleBrook Pharmaceuticals, Inc. (Filer) CIK: 0001161924 (see all company filings)

EIN.: 522208264 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50414 | Film No.: 10962811
SIC: 2834 Pharmaceutical Preparations